BRIEF-Allergan announces FDA acceptance of NDA filing for oxymetazoline hci cream 1.0%

* Allergan announces FDA acceptance of NDA filing for oxymetazoline hci cream 1.0%
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.